Hennion & Walsh Asset Management, Inc. Cassava Sciences Inc Transaction History
Hennion & Walsh Asset Management, Inc.
- $1.89 Billion
- Q2 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 24,881 shares of SAVA stock, worth $250,800. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,881
Previous 25,092
0.84%
Holding current value
$250,800
Previous $509,000
39.69%
% of portfolio
0.02%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding SAVA
# of Institutions
171Shares Held
11.3MCall Options Held
1.61MPut Options Held
1.43M-
Black Rock Inc. New York, NY3.05MShares$30.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA1.09MShares$11 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA902KShares$9.09 Million0.0% of portfolio
-
Gallacher Capital Management LLC Lone Tree, CO585KShares$5.9 Million6.03% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $404M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...